Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Prostate Cancer

  Free Subscription


15.07.2024

1 Am J Clin Oncol
2 BJU Int
1 BMC Cancer
1 Br J Cancer
1 Cancer Imaging
1 Cancer Res
1 Clin Cancer Res
1 Eur Radiol
1 Int J Radiat Oncol Biol Phys
1 Int J Urol
1 J Nucl Med
3 J Urol
1 Nat Rev Urol
1 PLoS One
2 Prostate


   Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Clin Oncol

  1. LEHRER S, Rheinstein PH
    Salbutamol, a Short Acting Beta-2 Agonist, Reduces Risk and Improves Prognosis of Prostate Cancer.
    Am J Clin Oncol. 2024 Jul 8. doi: 10.1097/COC.0000000000001134.
    PubMed         Abstract available


    BJU Int

  2. WENZEL M, Hoeh B, Koll F, Humke C, et al
    Impact of homologous recombination repair/BReast CAncer (BRCA) gene alterations on survival in a real-world setting of metastatic prostate cancer.
    BJU Int. 2024 Jul 10. doi: 10.1111/bju.16462.
    PubMed         Abstract available

  3. SCHMIDT B, Soerensen SJC, Bhambhvani HP, Fan RE, et al
    External validation of an artificial intelligence model for Gleason grading of prostate cancer on prostatectomy specimens.
    BJU Int. 2024 Jul 11. doi: 10.1111/bju.16464.
    PubMed         Abstract available


    BMC Cancer

  4. WANG Z, Liu H, Zhu Q, Chen J, et al
    Analysis of the immune-inflammatory indices for patients with metastatic hormone-sensitive and castration-resistant prostate cancer.
    BMC Cancer. 2024;24:817.
    PubMed         Abstract available


    Br J Cancer

  5. PUJANA-VAQUERIZO M, Bozal-Basterra L, Carracedo A
    Metabolic adaptations in prostate cancer.
    Br J Cancer. 2024 Jul 5. doi: 10.1038/s41416-024-02762.
    PubMed         Abstract available


    Cancer Imaging

  6. KALLIS K, Conlin CC, Zhong AY, Hussain TS, et al
    Comparison of synthesized and acquired high b-value diffusion-weighted MRI for detection of prostate cancer.
    Cancer Imaging. 2024;24:89.
    PubMed         Abstract available


    Cancer Res

  7. SHRESTHA R, Chesner LN, Zhang M, Zhou S, et al
    An Atlas of Accessible Chromatin in Advanced Prostate Cancer Reveals the Epigenetic Evolution during Tumor Progression.
    Cancer Res. 2024 Jul 11. doi: 10.1158/0008-5472.CAN-24-0890.
    PubMed         Abstract available


    Clin Cancer Res

  8. SWEENEY CJ, Petry R, Xu C, Childress M, et al
    Circulating Tumor DNA Assessment for Treatment Monitoring Adds Value to PSA in Metastatic Castration Resistant Prostate Cancer.
    Clin Cancer Res. 2024 Jul 11. doi: 10.1158/1078-0432.CCR-24-1096.
    PubMed         Abstract available


    Eur Radiol

  9. AGROTIS G, Pooch E, Abdelatty M, Benson S, et al
    Diagnostic performance of ADC and ADCratio in MRI-based prostate cancer assessment: A systematic review and meta-analysis.
    Eur Radiol. 2024 Jul 12. doi: 10.1007/s00330-024-10890.
    PubMed         Abstract available


    Int J Radiat Oncol Biol Phys

  10. TOESCA DAS, Hartsell WF, DeWees TA, Chang JH, et al
    Stereotactic Body Proton Therapy Versus Conventionally Fractionated Proton Therapy for Early Prostate Cancer: A Randomized, Controlled, Phase 3 Trial.
    Int J Radiat Oncol Biol Phys. 2024 Jul 5:S0360-3016(24)00669.
    PubMed         Abstract available


    Int J Urol

  11. DELLA CORTE M, Checcucci E
    Editorial Comment on "The role of lipidic balance on erectile dysfunction in prostate cancer patients undergoing robotic surgery".
    Int J Urol. 2024 Jul 9. doi: 10.1111/iju.15543.
    PubMed        


    J Nucl Med

  12. BUTEAU JP, Kostos L, Alipour R, Jackson P, et al
    Clinical Trial Protocol for VIOLET: A Single-Center, Phase I/II Trial Evaluation of Radioligand Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer with [(161)Tb]Tb-PSMA-I&T.
    J Nucl Med. 2024 Jul 11:jnumed.124.267650. doi: 10.2967/jnumed.124.267650.
    PubMed         Abstract available


    J Urol

  13. GIESEN A, Devos G, Everaerts W, Joniau S, et al
    Letter: A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.
    J Urol. 2024 Jul 8:101097JU0000000000004127. doi: 10.1097/JU.0000000000004127.
    PubMed        

  14. NIU S, Ding X, Liu B, Ao L, et al
    Radical Prostatectomy Without Prior Biopsy in Selected Patients Evaluated by (18)F-Labeled Prostate-Specific Membrane Antigen-Ligand Positron Emission Tomography/Computed Tomography and Multiparameter Magnetic Resonance Imaging: A Single-Center, Prosp
    J Urol. 2024;212:280-289.
    PubMed         Abstract available

  15. VICKERS A, Vertosick E, Langsetmo L, Dahm P, et al
    Estimating the Effect of Radical Prostatectomy: Combining Data From the SPCG4 and PIVOT Randomized Trials With Contemporary Cohorts.
    J Urol. 2024;212:310-319.
    PubMed         Abstract available


    Nat Rev Urol

  16. BAKHT MK, Beltran H
    Biological determinants of PSMA expression, regulation and heterogeneity in prostate cancer.
    Nat Rev Urol. 2024 Jul 8. doi: 10.1038/s41585-024-00900.
    PubMed         Abstract available


    PLoS One

  17. GUO H, Zhang L, Shao Y, An K, et al
    The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0301653.
    PubMed         Abstract available


    Prostate

  18. WENZEL M, Wagner N, Hoeh B, Siech C, et al
    Survival of patients with lymph node versus bone versus visceral metastases according to CHAARTED/LATITUDE criteria in the era of intensified combination therapies for metastatic hormone-sensitive prostate cancer.
    Prostate. 2024 Jul 10. doi: 10.1002/pros.24767.
    PubMed         Abstract available

  19. TANEGASHIMA T, Shiota M, Tsukahara S, Mutaguch J, et al
    Impact of proton pump inhibitors on the efficacy of androgen receptor signaling inhibitors in metastatic castration-resistant prostate cancer patients.
    Prostate. 2024 Jul 10. doi: 10.1002/pros.24769.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Prostate Cancer is free of charge.